dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· April 4, 2026

ServiceNow Partnerships Deepen AI Workflow Role Across Supply Chain And HR

View original at finance.yahoo.com
ServiceNow Partnerships Deepen AI Workflow Role Across Supply Chain And HR Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • ServiceNow sits at the center of a broad shift toward platforms that connect workflows across IT, operations, and business functions

    60% confidence
  • Expanding into more complex workflows in supply chain and multi function HR systems could test execution, a risk for new AI heavy use cases

    60% confidence
  • ServiceNow is being adopted as an AI-driven enterprise platform by new ecosystem partners and customers

    60% confidence
  • These are not lightweight plug-ins but full deployments aimed at coordinating real-world processes such as logistics, employee services, and IT incidents

    60% confidence
  • These are deep, system-of-record style integrations rather than one-off point tools

    60% confidence
  • ServiceNow aims to be an AI workflow platform at the center of large enterprises

    60% confidence
  • ServiceNow is being used as a common control layer for AI-powered workflows across supply chain, IT operations, security and HR

    60% confidence

Data points we hold from this source

ServiceNow · risk count0 count
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Sources réconciliées : aucun conflit ouvert pour l'instant.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,959
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,959 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
ServiceNow Partnerships Deepen AI Workflow Role Across Supply Chain And HR: Source | Via News | fr.via.news